Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 19.70
0.00 (0.00%)
Last updated: Oct 13, 2026, 11:16 AM CET
Biogened Market Cap
Biogened has a market cap or net worth of 48.39 million as of October 14, 2026. It is the 40,277th most valuable company in the world and the 351st biggest in Poland. Its market cap has decreased by 17.92% in one year.
Market Cap
48.39M
Enterprise Value
67.13M
Revenue
110.11M
Global Rank
Country Rank
#351 Poland
PE Ratio
9.54
ChartMarket Cap Chart
Since August 31, 2011, Biogened's market cap has increased from 45.77M to 48.39M, an increase of 5.73%. That is a compound annual growth rate of 0.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 48.88M | -7.87% |
| Dec 30, 2025 | 53.06M | -6.09% |
| Dec 30, 2024 | 56.50M | 27.78% |
| Dec 29, 2023 | 44.21M | 41.73% |
| Dec 29, 2022 | 31.20M | 47.67% |
| Dec 30, 2021 | 21.12M | 1.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.37B |
| NEUCA | 3.18B |
| Synektik Spólka Akcyjna | 3.03B |
| Voxel | 1.54B |
| Urteste | 65.16M |
| Read-Gene | 59.42M |
| Genomtec | 45.12M |
| MedApp | 45.02M |